Psorcon - General Information

Psorcon is a corticosteroid.


Pharmacology of Psorcon

Like other topical corticosteroids, diflorasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. Once absorbed through the skin, topical corticosteroids are handled through pharmacokinetic pathways similar to systemically administered corticosteroids. Psorcon is a potent topical corticosteroid that should not be used with occlusive dressings. It is recommended that treatment should be limited to 2 consecutive weeks and therapy should be discontinued when adequate results have been achieved.


Psorcon for patients

Patients using topical corticosteroids should receive the following information and instructions:

  1. This medication is to be used as directed by the physician. It is for external use only. Avoid contact with the eyes.
  2. Patients should be advised not to use this medication for any disorder other than for which it was prescribed.
  3. The treated skin area should not be bandaged or otherwise covered or wrapped as to be occlusive unless directed by the physician.
  4. Patients should report any signs of local adverse reactions especially under occlusive dressing.
  5. Parents of pediatric patients should be advised not to use tight-fitting diapers or plastic pants on an infant or child being treated in the diaper area, as these garments may constitute occlusive dressings.


Psorcon Interactions

No information provided.


Psorcon Contraindications

Topical steroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.


Additional information about Psorcon

Psorcon Indication: For relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
Mechanism Of Action: The precise mechanism of the antiinflammatory activity of topical steroids in the treatment of steroid-responsive dermatoses, in general, is uncertain. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2.
Drug Interactions: Not Available
Food Interactions: Not Available
Generic Name: Diflorasone
Synonyms: Diflorasone Diacetate
Drug Category: Anti-inflammatory Agents
Drug Type: Small Molecule; Approved

Other Brand Names containing Diflorasone: Florone; Florone E; Maxiflor; Psorcon;
Absorption: Topical corticosteroids can be absorbed from intact healthy skin. The extent of percutaneous absorption of topical corticosteroids is determined by many factors, including the vehicle and the integrity of the epidermal barrier. Occlusion, inflammation and/or other disease processes in the skin may also increase percutaneous absorption.
Toxicity (Overdose): Topically applied diflorasone can be absorbed in sufficient amounts to produce systemic effects. Symptoms of overdose include thinning of skin and suppression of adrenal cortex (decreased ability to respond to stress).
Protein Binding: Bound to plasma proteins in varying degrees.
Biotransformation: Metabolized, primarily in the liver, and then excreted by the kidneys.
Half Life: Not Available
Dosage Forms of Psorcon: Cream Topical
Chemical IUPAC Name: [(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-acetyloxyacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] acetate
Chemical Formula: C26H32F2O7
Diflorasone on Wikipedia:
Organisms Affected: Humans and other mammals